Investment firm Floor 13 has put an undisclosed amount into Reflux Medical, a diagnosis and therapy center specializing in the treatment of Reflux disease and medical conditions in the upper and lower intestinal tract. Specifics of the investment were not released. Reflux Medical is based in Vienna.
On July 23, 2012, Reflux Medical – a diagnosis and therapy center specializing in the treatment of Reflux disease and medical conditions in the upper and lower intestinal tract, starts service at Mariannengasse 10, A-1090 Vienna. “A holistic and innovative approach to the diagnosis, treatment and management of complex Reflux disease in combination with the highest medical standards, demonstrates the intrinsic value of this project„ says Stefan Schneider, managing partner of Floor 13.
“It is our professed aim to provide highest quality in terms of diagnosis, treatment, aftercare as well as individual medical care for our patients in a professional and pleasant environment.”
State of the art diagnosis and therapy procedures for a sustainable healing of Reflux disease is offered by independent medical practice of renowned experts.
Medical Director – Prof. Dr. Martin Riegler, who has dedicated many years to the holistic management and long term treatment as well as the healing of Reflux, has been highly recognized and internationally acclaimed for his professional approach.
Leading the Functional Diagnostics Surgical Department of the Medical University Clinic at the Vienna General Hospital (AKH), Prof. Riegler has been engaged with the research and development of innovative as well as efficient therapeutical measures relevant for the diagnosis and treatment of Reflux disease. The introduction of highly contemporary technologies and innovative therapeutic concepts enabled Prof. Riegler to develop a new dimension of Reflux management. „It is our ultimate goal to reinstate quality of life for people suffering from Reflux disease“, says Prof. Riegler.
Besides highly disbanding pressure measurement methods of the esophageal sphincter also combined with the Impedanz pH Metrie (Reflux-monitoring) and radiofrequency ablation (HALO®) for the treatment of Barrett Esophagus is being offered. For the diagnosis and treatment of Reflux, a novel biopsy protocol as well as a special surgical method for Reflux (Fundoplikatio) have been developed by Prof. Riegler. Several innovations are presented at international congresses and introduced in worldwide medical journals.
Prof. Dr. Martin Riegler has been the editor of the prestigious international surgical journal „European Surgery“ (Springer press) since 2003.
About Reflux Medical
“Both doctors and patients shall get the chance to focus on recovery; it is our aim to provide an ideal framework for this purpose”, says managing director Dr. Christian Tuscher. “ It is our professed aim to provide highest quality in terms of diagnosis, treatment, aftercare as well as individual medical care for our patients in a professional and pleasant environment.”
FLOOR13 is an owner operated investment and holding company with a business network of former entrepreneurs and executives. Different from classic investors, Floor 13 targets organic and substantial growth of business ventures rather than fast exit scenarios. It is an expressed philosophy to invest in companies operating below the scope of typical investment holdings.